@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-FGXV9PT8-9
  skos:prefLabel "Antinematodal Agents"@en, "Antihelminthiques antinématodes"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W47M8W34-W
  skos:prefLabel "Agonistes des acides aminés excitateurs"@fr, "Excitatory Amino Acid Agonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FXD7XKCS-G
  skos:prefLabel "Pyrrolidines"@en, "Pyrrolidines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-QGL2LW5L-3 .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QGL2LW5L-3
  skos:inScheme jvr: ;
  mesh:allowableQualifier jvr:-H7K65Q8S-Z, jvr:-W6SQV79N-S, jvr:-NFTHND7Q-8, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-TJHVZCRZ-0, jvr:-G4R176S9-J, jvr:-G30ZJ446-J, jvr:-NKM836P1-M, jvr:-WK5F724J-1, jvr:-THHNVC7V-3, jvr:-HQRFT0C6-B, jvr:-Q3979798-W, jvr:-FWD2BGQ0-9, jvr:-S0CS1X5R-5, jvr:-R0ZCQ8X6-J, jvr:-SBNWSM1T-R, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-NB0XHT3S-N, jvr:-D0F21513-5, jvr:-BT300B3G-Q, jvr:-R3QWLHRG-V, jvr:-XV06LPML-W, jvr:-T9HQD7ST-J ;
  skos:altLabel "SIV03811UC"@fr, "SIV03811UC"@en, "487-79-6 (Kainic Acid)"@fr, "487-79-6 (Kainic Acid)"@en, "3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2alpha,3beta,4beta))-"@en, "3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2alpha,3beta,4beta))-"@fr, "Digenic Acid"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-TG8LXFGC-F ;
  skos:hiddenLabel "Kainate"@en, "Kaïnate"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D007608> ;
  dc:modified "2016-05-31"^^xsd:date ;
  skos:prefLabel "Acide kaïnique"@fr, "Kainic Acid"@en ;
  mesh:pharmacologicalAction jvr:-FGXV9PT8-9, jvr:-W47M8W34-W ;
  skos:definition "(2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose."@en ;
  dc:established "1986-01-01"^^xsd:date ;
  dc:created "1977-04-22"^^xsd:date ;
  skos:broader jvr:-FXD7XKCS-G .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TG8LXFGC-F
  skos:prefLabel "Récepteurs kaïnate"@fr, "Receptors, Kainic Acid"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-QGL2LW5L-3 .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .